Real-world Impact of HPV Vaccination on CIN2+ Reduction: A Meta-Analysis of Observational Studies Assessing Variation by Age, Coverage, and Vaccine Type

Clicks: 2
ID: 319598
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #141 of 208 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 208 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Human papillomavirus (HPV) vaccination reduces the incidence of high-grade cervical lesions, but its population-level impact on cervical intraepithelial neoplasia grade 2 or worse (CIN2+) may vary by age at vaccination, program coverage, and vaccine type. The extent to which these factors explain variation in CIN2+ outcomes across real-world vaccination programs remains incompletely quantified. Methods Using data from a prior systematic review of observational studies across HPV-related endpoints, we restricted this meta-analysis to studies reporting histologically confirmed CIN2+. Reported ratio measures were analyzed on the natural log scale using random-effects models fitted by restricted maximum likelihood with Hartung–Knapp–Sidik–Jonkman inference. Prespecified subgroup analyses examined age at vaccination, vaccination coverage, and vaccine type. Exploratory univariable meta-regressions assessed follow-up duration, age-at-vaccination category, study design, and publication year. Sensitivity analyses evaluated the influence of effect-measure type, alternative between-study variance estimation, and trim-and-fill adjustment. A frequentist network meta-analysis compared vaccine types versus no vaccination. Results Twenty-two studies were included. HPV vaccination was associated with a pooled ratio estimate of 0.38 (95% CI 0.29–0.50), corresponding to an approximate 62% reduction in CIN2+ occurrence. Heterogeneity was very high (I2 = 97.0%), and the 95% prediction interval crossed 1 (0.12–1.23), indicating substantial variation in expected effects across real-world vaccination programs. Point estimates were generally protective across subgroup strata, but subgroup differences by age at vaccination, vaccination coverage, and vaccine type were not statistically significant. Sensitivity analyses were directionally consistent with the primary analysis. The network meta-analysis suggested lower CIN2+ occurrence for all vaccine-type categories compared with no vaccination; however, all comparisons were indirect through a common no-vaccination comparator, so vaccine-type differences should be interpreted as exploratory. Conclusions HPV vaccination was associated with a substantial average reduction in CIN2+ occurrence across observational studies. However, high heterogeneity, wide prediction intervals, non-significant subgroup tests, and indirect network comparisons indicate that subgroup and vaccine-type findings should be interpreted cautiously.
Reference Key
openalex_W7167269546 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Addisu Jember Zeleke, Laura Reifferscheid, Umar Yunusa, Megan Kennedy, Manish Sadarangani, G Ogilvie, Shannon E. MacDonald
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag420
URL
https://doi.org/10.1093/ofid/ofag420
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.